Identity
- Trade Name
- Calypso System FDA UDI
- Generic Name
- Radiation therapy invasive marker lesion localization system FDA UDI
- Device Name
- The Calypso System utilizes non-ionizing electromagnetic and optical technology to provide accurate, objective, and continuous localization of a treatment target for patient alignment and target position monitoring during radiation therapy. Use of the Calypso System for target localization is based on the system’s detection of electromagnetic signals from passive implanted markers, called Beacon transponders. The Beacon transponders are placed on the patient’s skin surface or implanted in or near the treatment target. When used with the Calypso System, the Beacon transponder signals enable objective, continuous measurement of the localization of the treatment target in 3 dimensions. The system operator uses this information for patient alignment and continuous target positioning (i.e., tracking) during radiation therapy treatment. FDA UDI
- Model / Reference
- 3 FDA UDI
- Description
- The Calypso System utilizes non-ionizing electromagnetic and optical technology to provide accurate, objective, and continuous localization of a treatment target for patient alignment and target position monitoring during radiation therapy. Use of the Calypso System for target localization is based on the system’s detection of electromagnetic signals from passive implanted markers, called Beacon transponders. The Beacon transponders are placed on the patient’s skin surface or implanted in or near the treatment target. When used with the Calypso System, the Beacon transponder signals enable objective, continuous measurement of the localization of the treatment target in 3 dimensions. The system operator uses this information for patient alignment and continuous target positioning (i.e., tracking) during radiation therapy treatment. FDA UDI
Identifiers
- Catalog Number
- ASM0195 FDA UDI
- Primary DI / UDI-DI
- 00850011006115 FDA UDI
- 510(k) Number
- K123137 FDA UDI
- FDA Product Code
- IYE FDA UDI
- GMDN Term
- Radiation therapy invasive marker lesion localization system FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 892.5050 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
No
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
No
FDA UDI
Serial Number
Yes
FDA UDI
Expiration Date
No
FDA UDI
Manufacturing Date
Yes
FDA UDI
Category: Radiation therapy invasive marker lesion localization system
Calypso System by Varian Medical Systems, Inc — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Radiation therapy invasive marker lesion localization system.
- Raypilot Table Displacement Meter — Micropos Medical AB (Publ) · Class II
- Raypilot Extension Plate — Micropos Medical AB (Publ) · Class II
- Raypilot Matching Network — Micropos Medical AB (Publ) · Class II
- Raypilot Transmitter Tester — Micropos Medical AB (Publ) · Class II
- Raypilot Receiver — Micropos Medical AB (Publ) · Class II
- Raypilot Power Box — Micropos Medical AB (Publ) · Class II
- Raypilot Software — Micropos Medical AB (Publ) · Class II
- Raypilot System Cable — Micropos Medical AB (Publ) · Class II
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Varian Medical Systems, Inc
Sources (1)
- FDA UDI f2b8e722-ed79-4dd8-b8bb-b345f65b146e 36 fields · synced May 30, 2026